Ovarian cancer: linking genomics to new target dis...[Adv Exp Med Biol. 2008]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Ovarian cancer: linking genomics to new target discovery and molecular markers--the way ahead.

Department of Molecular Therapeutics, MD Anderson Cancer Center, Houston, TX, USA.

PMID: 18497028 [PubMed - indexed for MEDLINE]

ReviewBiomarker discovery in epithelial ovarian cancer by genomic approaches.
Adv Cancer Res. 2007; 96:1-22.

[Adv Cancer Res. 2007]
ReviewGeneral keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.
Gynecol Oncol. 2003 Jan; 88(1 Pt 2):S25-8; discussion S37-42.

[Gynecol Oncol. 2003]
ReviewBiomarker discovery in ovarian cancer.
Womens Health (Lond Engl). 2008 Jan; 4:27-40.

[Womens Health (Lond Engl). 2008]
Review[Molecular markers in ovarian cancer]
Ginekol Pol. 1998 Feb; 69(2):94-7.

[Ginekol Pol. 1998]
ReviewBiomarkers of ovarian tumours.
Eur J Cancer. 2004 Nov; 40(17):2604-12.

[Eur J Cancer. 2004]
» See reviews... | » See all...

Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
Murph MM, Liu W, Yu S, Lu Y, Hall H, Hennessy BT, Lahad J, Schaner M, Helland A, Kristensen G, et al. PLoS One. 2009; 4(5):e5583. Epub 2009 May 15.

[PLoS One. 2009]

Your browsing activity is empty.

Activity recording is turned off.

Display Show